Part B: mRNA-1365, Dose 2 (Age Group: 5 to <8 months) for Respiratory Syncytial Virus
Study Summary
This trial tests the safety and effectiveness of two vaccines for RSV and hMPV in babies and toddlers.
- Respiratory Syncytial Virus
- Human Metapneumovirus
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 4 Secondary · Reporting Duration: Baseline up to Month 12
Trial Safety
Safety Progress
Trial Design
8 Treatment Groups
Part B: mRNA-1365, Dose 2 (Age Group: 5 to <8 months)
1 of 8
Part B: mRNA-1345 Dose 1 (Age Group: 5 to <8 months)
1 of 8
Part B: mRNA-1345, Dose 2 (Age Group: 5 to <8 months)
1 of 8
Part A: mRNA-1345, Dose 1 (Age Group: 8 to <24 months)
1 of 8
Part A: mRNA-1365, Dose 1 (Age Group: 8 to <24 months)
1 of 8
Part B: mRNA-1365 Dose 1 (Age Group: 5 to <8 months)
1 of 8
Part A: Placebo (Age Group: 8 to <24 months)
1 of 8
Part B: Placebo (Age Group: 5 to <8 months)
1 of 8
Experimental Treatment
Non-Treatment Group
210 Total Participants · 8 Treatment Groups
Primary Treatment: Part B: mRNA-1365, Dose 2 (Age Group: 5 to <8 months) · Has Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 5 - 24 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are geriatric patients being accepted for participation in this trial?
"This study is recruiting patients that fall between 5 and 24 Months of age." - Anonymous Online Contributor
What is the maximum capacity of participants for this clinical trial?
"ModernaTX, Inc. is performing the trial from two sites; SEC Clinical Research in Andalusia and Los Angeles Children's Hospital. To complete this study a total of 210 eligible patients are needed for enrollment." - Anonymous Online Contributor
Could you provide information regarding the current enrollment status of this research?
"According to the clinicaltrials.gov platform, this research opportunity is presently seeking participants. It was initiated on February 15th 2023 and subsequently updated on that same day." - Anonymous Online Contributor
Does my profile fulfill the criteria to join this experimental research?
"This clinical trial is recruiting 210 young children with respiratory syncytial virus, aged between 5 months and 24 months. Qualified applicants must meet these criteria to partake in the study." - Anonymous Online Contributor
To what extent is Part A: mRNA-1345, Dose 1 (Age Group: 8 to <24 months) a hazard for human beings?
"Assessed on a scale of 1 to 3, the safety rating for Part A: mRNA-1345, Dose 1 (Age Group: 8 to <24 months) is estimated at 1 due to its Phase 1 status - meaning that only minimal data exists in regard to both safety and efficacy." - Anonymous Online Contributor
How many medical sites are currently administering this clinical trial?
"This clinical trial has recruited patients from 29 different locations, such as SEC Clinical Research in Andalusia, Los Angeles Children's Hospital in Los Angeles, and Meridian Clinical Research in Washington." - Anonymous Online Contributor